PP
COLL icon

Paloma Partners’s Collegium Pharmaceutical COLL Stock Holding History

Paloma Partners’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-11,821
Closed -$179K – 1786
2019
Q1 		$179K Buy
+11,821
New +$189K ﹤0.01% 1541
2018
Q2 		– Sell
-21,381
Closed -$546K – 1698
2018
Q1 		$546K Buy
+21,381
New +$509K 0.01% 1310

Other funds holding COLL

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Paloma Partners's COLL Position: Q2 2019 in Review

Paloma Partners sold out of Collegium Pharmaceutical (COLL) in Q2 2019, closing a stake of 11,821 shares — an estimated $179K sold.

Paloma Partners first reported a position in COLL in Q1 2018 and held it in 2 quarters. The position peaked at $546K in Q1 2018. 128 funds tracked by Wall St. Rank hold COLL as of Q2 2019.

  • Paloma Partners reported no remaining Collegium Pharmaceutical position as of Q2 2019 after selling out during the quarter.
  • Paloma Partners sold 11,821 Collegium Pharmaceutical shares in Q2 2019, an estimated $179K.
  • Paloma Partners first reported a position in Collegium Pharmaceutical in Q1 2018 and held it in 2 quarters.
  • Paloma Partners's Collegium Pharmaceutical position peaked at $546K in Q1 2018.
  • 128 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2019.

Based on Paloma Partners's 13F filing for Q2 2019, filed 14 Aug 2019.